Stress Urinary Incontinence Device Market
完整報告名稱與涵蓋範圍
Stress Urinary Incontinence Device Market Size, Share & Trends Analysis Report By Product (Sling Systems, Vaginal Pessary Devices, Artificial Urinary Sphincter (AUS), Pelvic Floor Muscle Stimulator, and Injectable Urethral Bulking Agents/Injections), By End-Users, Region And Segment Forecasts, 2025-2034
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Stress Urinary Incontinence Device Market is anticipated to register a CAGR of 5.5%.
Stress Urinary Incontinence Device covers There are numerous sources of SUI which comprise pregnancy, childbirth (particularly where forceps were needed), weight gain, and chronic straining or coughing. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Stress Urinary Incontinence Device Market Snapshot
Chapter 4. Global Stress Urinary Incontinence Device Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Dynamics - Drivers
4.3. Challenges/Restraints
4.4. Market Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. SUI Epidemiology Analysis in Key Countries 2019
4.7. COVID 19 Impact on Medical Device Industry 2020
Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Sling Systems
5.2.2. Vaginal Pessary Devices
5.2.3. Artificial Urinary Sphincter (AUS)
5.2.4. Pelvic Floor Muscle Stimulator
5.2.5. Injectable Urethral Bulking Agents/Injections
Chapter 6. Stress Urinary Incontinence Device Market Segmentation 2: End-user Estimates & Trend Analysis
6.1. End-user Analysis & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
6.2.1. Hospitals
6.2.2. Gynecological Clinics
6.2.3. Homecare Settings
Chapter 7. Stress Urinary Incontinence Device Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.1.2. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.1.3. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.2.2. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.2.3. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.3.2. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.3.3. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.4.2. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.4.3. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.5.2. MEA Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.5.3. MEA revenue Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.5.3.1. South Africa
7.5.3.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Coloplast A/S
8.2.1.1. Company Overview
8.2.1.2. Financials
8.2.1.3. Product portfolio
8.2.1.4. Business strategy & Recent developments
8.2.2. Contura Ltd.
8.2.3. Elidah, Inc.
8.2.4. Laborie, Inc. (Cogentix Medical)
8.2.5. Atlantic Therapeutic
8.2.6. Boston Scientific Corporation,
8.2.7. Johnson & Johnson Services. Inc.
8.2.8. BD
8.2.9. CooperSurgical, Inc.
8.2.10. MEDGYN PRODUCTS, INC.
8.2.11. Cousin Biotech
8.2.12. Caldera Medical
8.2.13. Betatech Medical
8.2.14. FEG Textiltechnik mbH.
8.2.15. Affluent Medical
8.2.16. pfm medical ag
8.2.17. Betatech Medical
8.2.18. Caldera Medical Inc
8.2.19. Neomedic International
8.2.20. UROMED
8.2.21. Zephyr Surgical Implants
8.2.22. Viveve Medical, Inc.
8.2.23. UroMems
8.3. List of Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們